{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:52:57Z","timestamp":1762311177564,"version":"build-2065373602"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["853932"],"award-info":[{"award-number":["853932"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biopha.2025.117941","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:32:22Z","timestamp":1740641542000},"page":"117941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Phenothiazines boost host control of Mycobacterium avium infection in primary human macrophages"],"prefix":"10.1016","volume":"185","author":[{"given":"G\u00fcl","family":"Kilin\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom H.M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anno","family":"Saris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"11","key":"10.1016\/j.biopha.2025.117941_bib2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","article-title":"The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review","volume":"18","author":"Brode","year":"2014","journal-title":"Int. J. Tuberc. lung Dis."},{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thx.2006.070797","article-title":"Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003","volume":"62","author":"Marras","year":"2007","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid2206.151642","article-title":"Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014","volume":"22","author":"Ringshausen","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Resp. Crit. Care"},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib6","doi-asserted-by":"crossref","first-page":"1601855","DOI":"10.1183\/13993003.01855-2016","article-title":"Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases","volume":"49","author":"Ingen","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin. Chest Med"},{"issue":"11","key":"10.1016\/j.biopha.2025.117941_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/17476348.2021.1987891","article-title":"Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments","volume":"15","author":"van Ingen","year":"2021","journal-title":"Expert Rev. Resp. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2014.10.001","article-title":"Pathogenesis and Risk Factors for Nontuberculous Mycobacterial Lung Disease","volume":"36","author":"Honda","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0033-1333573","article-title":"Underlying host risk factors for nontuberculous mycobacterial lung disease","volume":"34","author":"Chan","year":"2013","journal-title":"Semin Respir. Crit. Care Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.115.4.1033","article-title":"Mycobacterium avium-intracellulare Pulmonary Infection in HIV-Negative Patients Without Preexisting Lung Disease: Diagnostic and Management Limitations","volume":"115","author":"Huang","year":"1999","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-013-1962-1","article-title":"Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis","volume":"33","author":"Xu","year":"2014","journal-title":"Eur. J. Clin. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4046\/trd.2018.0060","article-title":"Treatment of Mycobacterium avium Complex Pulmonary Disease","volume":"82","author":"Kwon","year":"2019","journal-title":"Tube Respir. Dis. (Seoul. )"},{"issue":"163","key":"10.1016\/j.biopha.2025.117941_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0212-2021","article-title":"Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments","volume":"31","author":"Kumar","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/biology10020096","article-title":"Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models","volume":"10","author":"Saxena","year":"2021","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0024-2016","article-title":"Nontuberculous Mycobacteria\u2014Overview","volume":"5","author":"Koh","year":"2017","journal-title":"Microbiol. Spectr."},{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00812-20","article-title":"Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response","volume":"89","author":"Shamaei","year":"2021","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2025.117941_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/microorganisms8091298","article-title":"Formation and Maturation of the Phagosome: A Key Mechanism in Innate Immunity against Intracellular Bacterial Infection","volume":"8","author":"Lee","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2025.117941_bib20","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fimmu.2017.01368","article-title":"Control of Phagocytosis by Microbial Pathogens","volume":"8","author":"Uribe-Querol","year":"2017","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-017-0517-0","article-title":"TLR4-NOX2 axis regulates the phagocytosis and killing of Mycobacterium tuberculosis by macrophages","volume":"17","author":"Lv","year":"2017","journal-title":"Bmc Pulm. Med"},{"issue":"14","key":"10.1016\/j.biopha.2025.117941_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147688","article-title":"Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases","volume":"22","author":"Li","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib23","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1038\/s41598-017-06700-3","article-title":"The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages","volume":"7","author":"Danelishvili","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.117941_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.micinf.2015.05.005","article-title":"Mycobacterium avium MAV_2941 mimics phosphoinositol-3-kinase to interfere with macrophage phagosome maturation","volume":"17","author":"Danelishvili","year":"2015","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0902-97","article-title":"Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae","volume":"32","author":"Ottenhoff","year":"2002","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2025.117941_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645485","article-title":"Repurposing Immunomodulatory Drugs to Combat Tuberculosis","volume":"12","author":"Fatima","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib27","doi-asserted-by":"crossref","first-page":"e01534","DOI":"10.1128\/mBio.01534-14","article-title":"Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens","volume":"5","author":"Czyz","year":"2014","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03024-22","article-title":"Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis","volume":"14","author":"Boland","year":"2023","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98980-z","article-title":"Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections","volume":"11","author":"Heemskerk","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41467-017-02777-6","article-title":"Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials","volume":"9","author":"Korbee","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117941_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.872361","article-title":"Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium","volume":"12","author":"Kilinc","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2025.117941_bib32","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: A case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharm. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib34","first-page":"CD003545","article-title":"Trifluoperazine for schizophrenia","volume":"2004","author":"Marques","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, Immunity, and Disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharm. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00167-24","article-title":"Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy","volume":"12","author":"Kilinc","year":"2024","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.biopha.2025.117941_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","article-title":"p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation","volume":"21","author":"Liu","year":"2016","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2025.117941_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fcell.2018.00147","article-title":"Selective Autophagy and Xenophagy in Infection and Disease","volume":"6","author":"Sharma","year":"2018","journal-title":"Front Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2025.117941_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121869","article-title":"Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.117941_bib40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fphar.2019.01029","article-title":"Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0\/G1 Arrest and Apoptosis","volume":"10","author":"Xia","year":"2019","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib41","article-title":"Functions of ROS in Macrophages and Antimicrobial Immunity","volume":"10","author":"Herb","year":"2021","journal-title":"Antioxid. (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46526-9","article-title":"Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses","volume":"9","author":"Charbonneau","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radic. Biol. Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2025.117941_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): The emerging role of H(2)S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1574-695X.2006.00203.x","article-title":"MnTBAP, a synthetic metalloporphyrin, inhibits production of tumor necrosis factor-alpha in lipopolysaccharide-stimulated RAW 264.7 macrophages cells via inhibiting oxidative stress-mediating p38 and SAPK\/JNK signaling","volume":"49","author":"Tumurkhuu","year":"2007","journal-title":"FEMS Immunol. Med Microbiol"},{"key":"10.1016\/j.biopha.2025.117941_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101466","article-title":"A closer look into NADPH oxidase inhibitors: Validation and insight into their mechanism of action","volume":"32","author":"Reis","year":"2020","journal-title":"Redox Biol."},{"issue":"18","key":"10.1016\/j.biopha.2025.117941_bib48","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s00018-012-1107-1","article-title":"VAS2870 is a pan-NADPH oxidase inhibitor","volume":"69","author":"Wingler","year":"2012","journal-title":"Cell Mol. Life Sci."},{"issue":"23","key":"10.1016\/j.biopha.2025.117941_bib49","doi-asserted-by":"crossref","first-page":"16188","DOI":"10.1074\/jbc.274.23.16188","article-title":"Titrating the effects of mitochondrial complex I impairment in the cell physiology","volume":"274","author":"Barrientos","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1471-4159.2001.00548.x","article-title":"DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria","volume":"79","author":"Votyakova","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0924-8579(03)00205-X","article-title":"The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus","volume":"22","author":"Hendricks","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189950","article-title":"Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity","volume":"13","author":"Nehme","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-8579(00)00199-0","article-title":"Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Bettencourt","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1-6","key":"10.1016\/j.biopha.2025.117941_bib54","first-page":"393","article-title":"THE ANTIBACTERIAL EFFECT OF SELECTED PHENOTHIAZINES AND THIOXANTHENES ON SLOW-GROWING MYCOBACTERIA","volume":"94B","author":"Kristiansen","year":"1986","journal-title":"Acta Pathol. Microbiol. Scand. Ser. B: Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044245","article-title":"Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis","volume":"7","author":"Advani","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib56","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/joc.1999.11.3.203","article-title":"In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine","volume":"11","author":"Gadre","year":"1999","journal-title":"J. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004850-199805000-00006","article-title":"Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis","volume":"13","author":"Gadre","year":"1998","journal-title":"Int Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1574-6968.1993.tb06337.x","article-title":"Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv","volume":"110","author":"Ratnakar","year":"1993","journal-title":"FEMS Microbiol Lett."},{"issue":"8","key":"10.1016\/j.biopha.2025.117941_bib60","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.02985-15","article-title":"Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases","volume":"60","author":"Deshpande","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00053-20","article-title":"New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection","volume":"11","author":"Andersson","year":"2020","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib63","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00326-16","article-title":"New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria","volume":"60","author":"Andersson","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01943-17","article-title":"Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics","volume":"62","author":"Andersson","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00301-17","article-title":"Lactoferricin Peptides Increase Macrophages' Capacity To Kill Mycobacterium avium","volume":"2","author":"Silva","year":"2017","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/j.biopha.2025.117941_bib66","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/iai.59.5.1823-1831.1991","article-title":"Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic","volume":"59","author":"Crowle","year":"1991","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/iai.52.1.252-262.1986","article-title":"Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium","volume":"52","author":"Frehel","year":"1986","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.biopha.2025.117941_bib68","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/2211-5463.12960","article-title":"Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma","volume":"10","author":"Li","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib69","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)33233-7","article-title":"Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships","volume":"222","author":"Prozialeck","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbamcr.2013.10.021","article-title":"The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer","volume":"1843","author":"Berchtold","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib71","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jat.4397","article-title":"The role of phenothiazine derivatives in autophagy regulation: A systematic review","volume":"43","author":"Otreba","year":"2023","journal-title":"J. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2004.07.016","article-title":"Mechanisms of mycobacterial persistence in tuberculosis","volume":"114","author":"Kusner","year":"2005","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.117941_bib73","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.166.5.3392","article-title":"Mycobacterium tuberculosis Phagosomes Exhibit Altered Calmodulin-Dependent Signal Transduction: Contribution to Inhibition of Phagosome-Lysosome Fusion and Intracellular Survival in Human Macrophages1","volume":"166","author":"Malik","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.03.005","article-title":"Rescue of Pink1 Deficiency by Stress-Dependent Activation of Autophagy","volume":"24","author":"Zhang","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib75","first-page":"69","article-title":"Inhibitors of Ca2+\u2009and K+\u2009transport enhance intracellular killing of M. tuberculosis by non-killing macrophages","volume":"22","author":"Martins","year":"2008","journal-title":"Vivo"},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib76","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2013.08.035","article-title":"Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection","volume":"145","author":"Conway","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.03.005","article-title":"Rescue of Pink1 Deficiency by Stress-Dependent Activation of Autophagy","volume":"24","author":"Zhang","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.biopha.2025.117941_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734229","article-title":"Reactive Oxygen Species in Macrophages: Sources and Targets","volume":"12","author":"Canton","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117941_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105295","article-title":"Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux","volume":"163","author":"Xia","year":"2021","journal-title":"Pharm. Res"},{"issue":"7344","key":"10.1016\/j.biopha.2025.117941_bib80","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature09973","article-title":"TLR signalling augments macrophage bactericidal activity through mitochondrial ROS","volume":"472","author":"West","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.117941_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.891475","article-title":"Pyruvate Supports RET-Dependent Mitochondrial ROS Production to Control Mycobacterium avium Infection in Human Primary Macrophages","volume":"13","author":"Rost","year":"2022","journal-title":"Front Immunol."},{"issue":"4143","key":"10.1016\/j.biopha.2025.117941_bib82","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","article-title":"Drugs, neurotransmitters, and schizophrenia","volume":"184","author":"Snyder","year":"1974","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2025.117941_bib83","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.117941_bib84","article-title":"Dopamine activates NF-\u03baB and primes the NLRP3 inflammasome in primary human macrophages","volume":"2","author":"Nolan","year":"2020","journal-title":"Brain, Behav., Immun. - Health"},{"key":"10.1016\/j.biopha.2025.117941_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1742-2094-9-203","article-title":"Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse","volume":"9","author":"Gaskill","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2025.117941_bib86","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11481-018-9825-2","article-title":"Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders","volume":"14","author":"Nolan","year":"2019","journal-title":"J. Neuroimmune Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2025.117941_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2011.00002","article-title":"Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?","volume":"2","author":"Sasindran","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2025.117941_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931876","article-title":"Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0014-2999(93)90488-4","article-title":"Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications","volume":"236","author":"Lahti","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib91","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jac\/dku036","article-title":"Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication","volume":"69","author":"Salie","year":"2014","journal-title":"J. Antimicrob. Chemoth"},{"issue":"3","key":"10.1016\/j.biopha.2025.117941_bib92","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2125.1983.tb01515.x","article-title":"Kinetics of oral trifluoperazine disposition in man","volume":"15","author":"Midha","year":"1983","journal-title":"Br. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.117941_bib93","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/17435390.2015.1107146","article-title":"Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish","volume":"10","author":"Vibe","year":"2016","journal-title":"Nanotoxicology"},{"issue":"11","key":"10.1016\/j.biopha.2025.117941_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10111365","article-title":"Mycobacterium avium Subsp. hominissuis Interactions with Macrophage Killing Mechanisms","volume":"10","author":"Abukhalid","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.biopha.2025.117941_bib95","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2958.2003.03438.x","article-title":"SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis","volume":"48","author":"Braunstein","year":"2003","journal-title":"Mol. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2025.117941_bib96","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2958.2004.04078.x","article-title":"Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst","volume":"52","author":"Ng","year":"2004","journal-title":"Mol. Microbiol"},{"issue":"14","key":"10.1016\/j.biopha.2025.117941_bib97","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1073\/pnas.92.14.6625","article-title":"Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria","volume":"92","author":"Sherman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117941_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739938","article-title":"Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of Salmonella enterica Serovar Typhimurium Infection in Human Macrophages","volume":"12","author":"van Doorn","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117941_bib99","article-title":"Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy","author":"Kilinc","year":"2024","journal-title":"Microbiol Spectr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:48:51Z","timestamp":1762310931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":99,"alternative-id":["S0753332225001350"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117941","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenothiazines boost host control of Mycobacterium avium infection in primary human macrophages","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117941"}}